-
Bharti Airtel
1,956.00 2,174.70(%) -
Bluestone Jewel
872.60 872.60(%) -
Anthem Bioscienc
735.10 579.45(%) -
IndusInd Bank
1,077.80 1,077.80(%) -
M & M Fin. Serv.
384.55 412.30(%) -
Data Pattern
4,800.00 4,955.00(%) -
TVS Motor Co.
3,965.00 3,970.00(%) -
Cummins India
5,635.00 6,142.80(%) -
Bajaj Auto
11,025.00 11,025.00(%) -
SBI Funds Mgt.
582.55 582.55(%) -
Bandhan Bank
169.65 134.30(%) -
HDFC Bank
750.25 726.75(%) -
Kalyan Jewellers
601.25 617.30(%) -
Eternal
275.70 212.55(%) -
Reliance Industries
1,284.00 1,253.65(%) -
Bajaj Finance
1,056.30 788.40(%) -
Dixon Technolog.
13,650.00 9,605.05(%) -
Himadri Special
760.20 420.00(%) -
Titan Company
4,730.10 4,730.10(%) -
Nestle India
1,509.75 1,509.75(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 4164.0
- ISIN : INE782E01017
-
Today’s Low
2,401.00 -
Today’s High
2,468.70
-
Open
2,450.00 -
Perv Close
2,450.00 -
52W Low
1,239.30 -
52W High
2,660.00
Key Indicators
-
P/E(TTM)
43.95
-
Mar.Cap (₹Cr.)
2,068.02
-
Div & Yield %
0.45
-
Book Value(₹)
452.79
-
Debt-Equity Ratio
-0.78
-
AGM Date
22-Jul-2026
-
EPS
55.27
-
P/E Ratio
43.95
Financials Ratios
-
Debt-Equity Ratio
0.91
-
Mar.Cap (₹Cr.)
2,068.02
-
RONW (%)
7.41
-
ROCE (%)
8.74
Score Board
-
Equity (₹ in Cr.)
8.51
-
BV (₹)
452.80
-
Sales( ₹ in Cr.)
292.14
-
NP (in Cr.)
47.02
-
NP Var(%)
46.0
-
Div%
110.0
-
CPS (₹)
67.30
-
EPS (₹)
55.30
-
Traded Value (₹ in Lakhs)
2,066.53
-
52 Week High
2,660.00
-
52 Week Low
1,239.30
-
Price BSE
2429.0
-
Price NSE
2,431.00
-
Market Capital( in Cr.)
2,066.53
-
P/C Ratio
36.10
-
P/E Ratio
43.90
-
Price Vs.BV
55.30
-
13-Jul-2026( 12:15)
Hot Pursuit - Heste... - <p>Shardul Securities Ltd, BF...
-
18-Jun-2026( 05:28)
Corporate News - Heste... - Hester Biosciences announced t...
-
15-May-2026( 02:10)
Corporate News - Board... - Hester Biosciences announced t...
-
15-May-2026( 01:58)
Results - Announcements - Heste... - Net profit of Hester Bioscienc...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 292.14 | 286.47 | 285.16 | 254.00 | 219.35 | 208.48 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 292.14 | 286.47 | 285.16 | 254.00 | 219.35 | 208.48 |
| Other Income | 14.63 | 4.76 | 4.26 | 5.32 | 4.66 | 1.65 |
| Stock Adjustments | 3.69 | -9.97 | -10.36 | 4.77 | 12.53 | -4.01 |
| Total Income | 310.46 | 281.26 | 279.06 | 264.09 | 236.54 | 206.12 |
| EXPENDITURE : | ||||||
| Raw Materials | 85.66 | 83.70 | 89.28 | 84.65 | 76.37 | 49.38 |
| Power and Fuel Cost | 9.20 | 10.12 | 12.34 | 9.95 | 8.74 | 6.93 |
| Employee Cost | 53.17 | 54.76 | 56.72 | 47.92 | 39.12 | 33.45 |
| Other Manufacturing Expenses | 15.23 | 14.07 | 14.49 | 7.57 | 6.89 | 5.46 |
| Selling and Administration Expenses | 49.88 | 54.45 | 50.25 | 49.26 | 34.94 | 32.24 |
| Miscellaneous Expenses | 10.21 | 8.46 | 4.37 | 4.55 | 5.26 | 10.28 |
| Employee Benefit Expenses | 53.17 | 54.76 | 56.72 | 47.92 | 39.12 | 33.45 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 223.36 | 225.56 | 227.45 | 203.88 | 171.31 | 137.74 |
| Operating Profit | 87.10 | 55.71 | 51.60 | 60.21 | 65.23 | 68.37 |
| Interest | 7.17 | 5.37 | 5.09 | 6.50 | 2.47 | 3.95 |
| Gross Profit | 79.93 | 50.34 | 46.51 | 53.71 | 62.76 | 64.42 |
| Depreciation | 10.25 | 8.58 | 9.78 | 9.79 | 9.50 | 9.63 |
| Profit Before Tax | 69.68 | 41.76 | 36.73 | 43.92 | 53.26 | 54.79 |
| Current Tax | 14.47 | 11.27 | 9.64 | 10.73 | 14.25 | 16.37 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.12 | -1.35 | -0.06 | 0.86 | -0.51 | -1.48 |
| Reported Net Profit | 52.10 | 31.84 | 27.16 | 32.34 | 39.52 | 39.90 |
| Extraordinary Items | 5.08 | -0.35 | 0.02 | 0.01 | 0.09 | -3.69 |
| Adjusted Net Profit | 47.02 | 32.19 | 27.14 | 32.33 | 39.43 | 43.59 |
| Adjustment below Net Profit | -0.05 | -0.36 | -0.02 | 0.11 | -0.16 | 0.21 |
| P & L Balance brought forward | 272.91 | 246.53 | 226.20 | 202.25 | 171.40 | 136.90 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 5.96 | 5.10 | 6.81 | 8.51 | 8.51 | 5.62 |
| P & L Balance carried down | 319.00 | 272.91 | 246.53 | 226.20 | 202.25 | 171.40 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 110.00 | 70.00 | 60.00 | 80.00 | 100.00 | 100.00 |
| Dividend Per Share(Rs) | 11.00 | 7.00 | 6.00 | 8.00 | 10.00 | 10.00 |
| Earnings Per Share-Unit Curr | 61.24 | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 |
| Earnings Per Share(Adj)-Unit Curr | 61.24 | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 |
| Book Value | 452.78 | 398.60 | 367.59 | 343.70 | 315.54 | 279.28 |
| Book Value(Adj)-Unit Curr | 452.78 | 398.60 | 367.59 | 343.70 | 315.54 | 279.28 |
